Jim Januzzi, MD, outlines a multitude of drug treatment options for heart failure revolving around patient ejection fraction (EF) status. Ryan Haumschild, PharmD, MS, MBA: As we start to transition ...

Heart failure with preserved ejection fraction (HFpEF) is a type of heart failure that affects the left side of the heart. It occurs when the lower left chamber of the heart, called the left ventricle ...

Patients with symptomatic heart failure (HF) and normal to near-normal ejection fraction (EF) have different pathophysiological alterations compared with those with HF and low EF, and current ...

Population-based studies report that the majority of elderly patients with heart failure have a normal ejection fraction (HF-NEF) and a history of hypertension. Left ventricular diastolic dysfunction, ...

Heart failure with preserved ejection fraction (HFpEF) has limited treatment options and remains a medical challenge. HFpEF is characterized by diastolic dysfunction with a normal ejection fraction.

If you practice inpatient medicine, you've managed patients with heart failure with preserved ejection fraction (HFpEF). Formerly known as diastolic dysfunction, HFpEF is borderline ubiquitous on the ...

Background and objectives Implantable cardioverter defibrillator (ICD) therapy is indicated following a myocardial infarction ...

If you’ve been diagnosed with heart failure, your doctor has likely ordered a test of your heart's ejection fraction (EF). The EF is a measure of how efficiently your heart is pumping blood out to the ...

A new study led by researchers at Wake Forest University School of Medicine has found that artificial intelligence (AI) can ...